Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
Tag: weight management
Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients ...
Electronic health record-based weight maintenance coaching
1. This randomized controlled trial showed a mean weight difference of -2.86 kg at 24 months and -3.21 kg at ...